CanSino’s 23% Stock Slump Shows Perils of Chasing Vaccine Hype

Bookmark
(Bloomberg) -- The air has suddenly come out of a rally in a biotech firm that’s been working with China’s military to develop a coronavirus vaccine.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.